Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and

H Schröder1, D F Wu, A Seifert

  • 1Dept of Pharmacology and Toxicology, Otto-von-Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany. helmut.schroeder@med.ovgu.de

Neuropharmacology
|January 24, 2009
PubMed

Insights

Metabotropic glutamate receptor 5 (mGluR5) allosterically modulates micro-opioid receptor (MOR) signaling. Blocking mGluR5 with MPEP reduces opioid-induced MOR desensitization, suggesting receptor interaction.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Opioid analgesia and tolerance are influenced by metabotropic glutamate receptors.
  • Micro-opioid receptor (MOR) and metabotropic glutamate receptor 5 (mGluR5) are key targets in pain and addiction research.

Purpose of the Study:

  • To investigate the functional coupling and desensitization of MOR when co-expressed with mGluR5.
  • To determine if mGluR5 allosterically modulates MOR signaling and desensitization.

Main Methods:

  • Co-expression of MOR and mGluR5 in human embryonic kidney (HEK) 293 cells.
  • Assessing agonist binding and cAMP inhibition for MOR functional coupling.
  • Evaluating MOR phosphorylation, internalization, and desensitization using MPEP, a non-competitive mGluR5 antagonist.
  • Investigating receptor interaction via co-internalization, MPEP binding studies, and co-immunoprecipitation.

Main Results:

  • mGluR5 co-expression did not significantly alter MOR agonist binding or functional coupling.
  • The mGluR5 antagonist MPEP reduced DAMGO-induced MOR phosphorylation, internalization, and desensitization.
  • Evidence suggests MOR and mGluR5 interact or form heteromers, facilitated by MPEP.

Conclusions:

  • Allosteric modulation of mGluR5 impacts agonist-induced MOR signaling and regulation.
  • MOR and mGluR5 may form functional heteromers, influencing opioid receptor desensitization.
  • Targeting mGluR5 offers a potential strategy to modulate opioid receptor activity.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...